Photoinactivation of Trypanosoma cruzi in red cell suspensions with thiopyrylium.
Chagas disease, endemic in rural areas of Mexico, Central and South America, is caused by the protozoan parasite, Trypanosma cruzi, which is spread by the Reduviid bug and also by transfusion or organ transplant. Transmission of the organism from asymptomatic donors to immunocompromised recipients, leads to clinically apparent disease. With recent immigration patterns, T. cruzi is now becoming an increasing problem in non-endemic areas of North America and Europe. Blood screening tests for T. cruzi are being developed, and one test is currently licensed by the United States Food and Drug Administration and has been implemented in some US blood centers. This study alternatively investigates the potential for a novel DNA-intercalating photosensitizer, thiopyrylium (TP), to inactivate T. cruzi in red cell suspensions. With complete inactivation using 6.3 microM of TP and 1.1J/cm(2) red light treatment, results suggest that the organism is highly sensitive to photoinactivation under conditions much less stringent than those that have been previously demonstrated to maintain red cell (RBC) properties during 42 day storage.
Wagner
Stephen J
SJ
American Red Cross Holland Laboratory, Rockville, MD 20855, USA. wagners@usa.redcross.org
Skripchenko
Andrey
A
Salata
Jeanne
J
Cardo
Lisa J
LJ
D000818:Animals; D001771:Blood Banks; D001782:Blood Donors; D014355:Chagas Disease / Q000517:prevention & control* / Q000635:transmission; D003140:Communicable Disease Control; D046148:Donor Selection / Q000379:methods; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000469:parasitology*; D006801:Humans; D008800:Mexico; D017319:Photosensitizing Agents / Q000494:pharmacology*; D013020:South America; D013876:Thiophenes / Q000494:pharmacology*; D013997:Time Factors; D014225:Triatominae / Q000469:parasitology; D014349:Trypanosoma cruzi; D014481:United States; D014486:United States Food and Drug Administration
D017319:Photosensitizing Agents; D013876:Thiophenes; C521680:thiopyrylium
Vox Sang. 2006 Nov;91(4):285-91
17105603
Rev Soc Bras Med Trop. 2004 May-Jun;37(3):252-60
15330067
Expert Rev Cardiovasc Ther. 2006 Jan;4(1):119-30
16375634
Transfusion. 2002 May;42(5):549-55
12084162
MMWR Morb Mortal Wkly Rep. 2006 Jul 28;55(29):798-800
16874295
Vox Sang. 2007 Feb;92(2):157-9
17298580
Transfusion. 2005 May;45(5):752-60
15847665
Antimicrob Agents Chemother. 2003 Feb;47(2):475-9
12543646
Hum Exp Toxicol. 2006 Aug;25(8):471-9
16937919
Transfusion. 2006 Oct;46(10):1737-44
17002630
Vox Sang. 2006 Aug;91(2):178-80
16907880
Transfusion. 2004 May;44(5):731-8
15104655